These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 15732111

  • 1. Interaction of alpha-synuclein and tau genotypes in Parkinson's disease.
    Mamah CE, Lesnick TG, Lincoln SJ, Strain KJ, de Andrade M, Bower JH, Ahlskog JE, Rocca WA, Farrer MJ, Maraganore DM.
    Ann Neurol; 2005 Mar; 57(3):439-43. PubMed ID: 15732111
    [Abstract] [Full Text] [Related]

  • 2. Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease.
    Mellick GD, Maraganore DM, Silburn PA.
    Neurosci Lett; 2005 Feb 28; 375(2):112-6. PubMed ID: 15670652
    [Abstract] [Full Text] [Related]

  • 3. Microtubule-associated protein tau (MAPT) influences the risk of Parkinson's disease among Indians.
    Das G, Misra AK, Das SK, Ray K, Ray J.
    Neurosci Lett; 2009 Aug 21; 460(1):16-20. PubMed ID: 19450659
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. alpha-Synuclein promoter confers susceptibility to Parkinson's disease.
    Pals P, Lincoln S, Manning J, Heckman M, Skipper L, Hulihan M, Van den Broeck M, De Pooter T, Cras P, Crook J, Van Broeckhoven C, Farrer MJ.
    Ann Neurol; 2004 Oct 21; 56(4):591-5. PubMed ID: 15455394
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype.
    Khan N, Graham E, Dixon P, Morris C, Mander A, Clayton D, Vaughan J, Quinn N, Lees A, Daniel S, Wood N, de Silva R.
    Ann Neurol; 2001 May 21; 49(5):665-8. PubMed ID: 11357958
    [Abstract] [Full Text] [Related]

  • 8. Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset.
    Hadjigeorgiou GM, Xiromerisiou G, Gourbali V, Aggelakis K, Scarmeas N, Papadimitriou A, Singleton A.
    Mov Disord; 2006 Apr 21; 21(4):534-9. PubMed ID: 16250025
    [Abstract] [Full Text] [Related]

  • 9. Identification of a risk haplotype of the alpha-synuclein gene in Japanese with sporadic Parkinson's disease.
    Kobayashi H, Ujike H, Hasegawa J, Yamamoto M, Kanzaki A, Sora I.
    Mov Disord; 2006 Dec 21; 21(12):2157-64. PubMed ID: 17078049
    [Abstract] [Full Text] [Related]

  • 10. Correlation of tau gene polymorphism with age at onset of Parkinson's disease.
    Kobayashi H, Ujike H, Hasegawa J, Yamamoto M, Kanzaki A, Sora I.
    Neurosci Lett; 2006 Sep 25; 405(3):202-6. PubMed ID: 16876320
    [Abstract] [Full Text] [Related]

  • 11. Interaction between α-synuclein and tau genotypes and the progression of Parkinson's disease.
    Huang Y, Rowe DB, Halliday GM.
    J Parkinsons Dis; 2011 Sep 25; 1(3):271-6. PubMed ID: 23939307
    [Abstract] [Full Text] [Related]

  • 12. The tau gene haplotype h1 confers a susceptibility to Parkinson's disease.
    Zhang J, Song Y, Chen H, Fan D.
    Eur Neurol; 2005 Sep 25; 53(1):15-21. PubMed ID: 15627775
    [Abstract] [Full Text] [Related]

  • 13. Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease.
    Mizuta I, Satake W, Nakabayashi Y, Ito C, Suzuki S, Momose Y, Nagai Y, Oka A, Inoko H, Fukae J, Saito Y, Sawabe M, Murayama S, Yamamoto M, Hattori N, Murata M, Toda T.
    Hum Mol Genet; 2006 Apr 01; 15(7):1151-8. PubMed ID: 16500997
    [Abstract] [Full Text] [Related]

  • 14. Gene dosage and pathogenesis of Parkinson's disease.
    Eriksen JL, Przedborski S, Petrucelli L.
    Trends Mol Med; 2005 Mar 01; 11(3):91-6. PubMed ID: 15760766
    [Abstract] [Full Text] [Related]

  • 15. Association of tau gene polymorphism with Parkinson's disease.
    Zappia M, Annesi G, Nicoletti G, Serra P, Arabia G, Pugliese P, Messina D, Caracciolo M, Romeo N, Annesi F, Pasqua AA, Spadafora P, Civitelli D, Romeo N, Epifanio A, Morgante L, Quattrone A.
    Neurol Sci; 2003 Oct 01; 24(3):223-4. PubMed ID: 14600827
    [Abstract] [Full Text] [Related]

  • 16. [The alpha-synuclein gene microsatellite polymorphism and late-onset sporadic Parkinson's disease susceptibility].
    Zhao XP, Zheng HM, Xie HJ, Ding SJ, Ren DM.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug 01; 21(4):339-41. PubMed ID: 15300629
    [Abstract] [Full Text] [Related]

  • 17. Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease.
    Winkler S, König IR, Lohmann-Hedrich K, Vieregge P, Kostic V, Klein C.
    Eur J Hum Genet; 2007 Nov 01; 15(11):1163-8. PubMed ID: 17637803
    [Abstract] [Full Text] [Related]

  • 18. [alpha-Synuclein and familial Parkinson's disease].
    Iwatsubo T.
    No To Shinkei; 1999 Jun 01; 51(6):481-6. PubMed ID: 10423749
    [No Abstract] [Full Text] [Related]

  • 19. alpha-Synuclein gene and Parkinson's disease. The French Parkinson's Disease Study Group.
    Science; 1998 Feb 20; 279(5354):1116-7. PubMed ID: 9508681
    [No Abstract] [Full Text] [Related]

  • 20. Multiple regions of alpha-synuclein are associated with Parkinson's disease.
    Mueller JC, Fuchs J, Hofer A, Zimprich A, Lichtner P, Illig T, Berg D, Wüllner U, Meitinger T, Gasser T.
    Ann Neurol; 2005 Apr 20; 57(4):535-41. PubMed ID: 15786467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.